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execute diverse defense functions, which
are not fully understood. Iatsenko et al.
show that Drosophila PGRP-SD is a
secreted pattern-recognition receptor
required upstream of transmembrane
receptor PGRP-LC to enhance activation
of the Imd pathway by promoting
peptidoglycan re-localization to the cell
surface.
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Activation of the innate immune response in Meta-
zoans is initiated through the recognition of microbes
by host pattern-recognition receptors. In Drosophila,
diaminopimelic acid (DAP)-containing peptidoglycan
fromGram-negative bacteria is detected by the trans-
membrane receptor PGRP-LC and by the intracellular
receptor PGRP-LE. Here, we show that PGRP-SD
actedupstreamofPGRP-LCasanextracellular recep-
tor to enhance peptidoglycan-mediated activation of
Imdsignaling.Consistentwith this,PGRP-SDmutants
exhibited impaired activation of the Imd pathway and
increased susceptibility to DAP-type bacteria. PGRP-
SDenhanced the localization of peptidoglycans to the
cell surface andhence promoted signaling.Moreover,
PGRP-SD antagonized the action of PGRP-LB, an
extracellular negative regulator, to fine-tune the inten-
sity of the immune response. These data reveal that
Drosophila PGRP-SD functions as an extracellular re-
ceptor similar to mammalian CD14 and demonstrate
that, comparable to lipopolysaccharide sensing in
mammals, Drosophila relies on both intra- and extra-
cellular receptors for the detection of bacteria.
INTRODUCTION
The innate immune response is an important line of defense
against invading pathogens inMetazoans (Janeway andMedzhi-
tov, 2002; Lemaitre and Hoffmann, 2007). Like all invertebrates,
the fruit fly, Drosophila, relies exclusively on innate immunity
to fight off infections (Lemaitre and Hoffmann, 2007). Recogni-
tion of bacterial infection in this insect is mediated through
the sensing of peptidoglycans by a class of pattern-recognition
receptors (PRRs) called peptidoglycan recognition proteins
(PGRPs) (Leulier et al., 2003; Royet et al., 2011). PGRPs are
conserved from insects to mammals and are defined by the
presence of a 160 amino acid PGRP domain, which is similar
to that of bacterial N-acetylmuramyl-L-alanine amidases (Kur-
ata, 2014; Yoshida et al., 1996). Drosophila has 13 PGRP genesImmuencoding 19 known proteins, which execute multiple defense
functions (Royet et al., 2011). Some Drosophila PGRPs, known
as enzymatic PGRPs (e.g., PGRP-LB, PGRP-SC, and PGRP-
SB), cleave peptidoglycan into non-immunostimulatory frag-
ments by removing peptides from the glycan chains (Mellroth
et al., 2003; Zaidman-Re´my et al., 2011, 2006). In this way,
catalytic PGRPs either modulate the immune response by scav-
enging peptidoglycan or act as bactericidal molecules (Coste-
chareyre et al., 2016; Mellroth and Steiner, 2006; Paredes
et al., 2011; Zaidman-Re´my et al., 2011, 2006). In contrast,
non-catalytic PGRPs (e.g., PGRP-LC, PGRP-LE, and PGRP-
SA) have lost their enzymatic activity but have conserved their
ability to bind peptidoglycan. Non-catalytic PGRPs often func-
tion as PRRs, which mediate microbial ligand-dependent activa-
tion of downstream signaling (Royet et al., 2011).
Peptidoglycan is an essential component of the bacterial cell
wall, which consists of long glycan chains made of alternating
N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (Mur-
NAc) residues that are cross-linked by short peptide bridges
(Schleifer and Kandler, 1972). All Gram-negative and a subset
of Gram-positive bacteria (e.g., Bacillus) possess a diaminopi-
melic acid (DAP) residue at the third position of the peptide
bridge, whereas all other Gram-positive bacteria possess an
L-lysine at this position (Schleifer and Kandler, 1972). Application
of highly purified peptidoglycan preparations has shown that
Drosophila can discriminate between Lys-type and DAP-type
peptidoglycan-containing bacteria to elicit distinct antimicrobial
responses via the selective activation of the Toll and Imd path-
ways, respectively (Leulier et al., 2003; Stenbak et al., 2004; Ka-
neko et al., 2004). Lys-type Gram-positive bacteria are recog-
nized by a secreted PGRP, PGRP-SA, which activates the Toll
pathway to stimulate the expression of antimicrobial peptide
genes (e.g., Drosomycin) via the NF-kB members Dif and Dorsal
(Gobert et al., 2003; Valanne et al., 2011). The Toll pathway can
also be activated by fungi upon sensing of glucan by beta-1,3-
glucan binding protein GNBP3 or directly by microbial proteases
(Gottar et al., 2006). In contrast, Gram-negative and DAP-type
Gram-positive bacteria trigger the Imd pathway through the
NF-kB transcription factor Relish (Ferrandon et al., 2007; Kleino
and Silverman, 2014; Lemaitre and Hoffmann, 2007; Neyen and
Lemaitre, 2016). The transmembrane protein PGRP-LC is the
major receptor upstream of the Imd pathway (Gottar et al.,
2002; Choe et al., 2002). It is expressed as three splice isoformsnity 45, 1013–1023, November 15, 2016 ª 2016 Elsevier Inc. 1013
(LCa, LCx, and LCy), each consisting of the same intracellular
domain linked to a different extracellular domain (Kaneko et al.,
2004; Neyen et al., 2016). PGRP-LCx is sufficient to recognize
polymeric peptidoglycan, whereas detection of monomeric
peptidoglycan requires both PGRP-LCx and PGRP-LCa (Ka-
neko et al., 2004; Neyen et al., 2012). PGRP-LE is another
DAP-type peptidoglycan-binding protein regulating the Imd
pathway (Kaneko et al., 2006; Takehana et al., 2004). Whereas
activation of the Imd pathway in the fat body during systemic
infection relies mostly on PGRP-LC (Neyen et al., 2012; Take-
hana et al., 2004), PGRP-LE plays a major role in the response
to Gram-negative bacteria in the midgut (Bosco-Drayon et al.,
2012; Neyen et al., 2012). Negative regulation of the Imd pathway
is also critical for survival and occurs at multiple levels. Notably in
the hemolymph, secreted enzymatic PGRPs, such as PGRP-LB,
scavenge peptidoglycan, the bacterial elicitor of the pathway
(Zaidman-Re´my et al., 2006; Paredes et al., 2011). Thus, immune
response involving the Imd pathway is thought to require a bal-
ance between peptidoglycan sensing by recognition PGRPs
and peptidoglycan degradation by enzymatic PGRPs.
PGRP-SD is a short secreted protein that is strongly induced
upon infectionby the Imdpathway (DeGregorioet al., 2002).Crys-
tal-structureanalysishas revealed thatPGRP-SDholdsapeptido-
glycan-binding groove characteristic of DAP-type recognition
PGRPs (Leone et al., 2008). In vitro binding studies subsequently
confirmed that PGRP-SD binds DAP-type but not Lys-type pepti-
doglycan (Leone et al., 2008), suggesting a role for PGRP-SD in
the Imd pathway. However, a genetic analysis performed with a
presumptive null PGRP-SD mutant did not reveal any role for
PGRP-SD in the detection of Gram-negative bacteria (Bischoff
et al., 2004). Instead, Bischoff et al. (2004) showed that PGRP-
SD mutants are susceptible to Gram-positive bacteria and that
some Lys-type bacteria cause defects in activation of the Toll
pathway. Wang et al., (2008) confirmed that PGRP-SD interacts
with PGRP-SA and GNBP1 upstream of the Toll pathway (Wang
et al., 2008), and another study (Leone et al., 2008) has suggested
a role for PGRP-SD in Toll pathway activation by DAP-type
peptidoglycan-containingbacteria. Thesediscrepanciesbetween
structural and genetic studies prompted us to re-investigate the
role of PGRP-SD in the Drosophila immune response.
Using newly generated PGRP-SD mutants, we were able to
show that PGRP-SD was not required for Toll pathway activation
by Lys- or DAP-type bacteria. Instead, PGRP-SD mutants had
a reduced systemic Imd pathway activation and increased
susceptibility to Gram-negative bacteria. In addition, PGRP-SD
strongly enhanced peptidoglycan-mediated activation of the
Imd pathway by promoting peptidoglycan re-localization to
the cell-surface receptor PGRP-LC. All together, our results
provide strong genetic evidence that PGRP-SD is an important
DAP-type pattern-recognition protein required upstream of the
Imd pathway for defense against DAP-type peptidoglycan-con-
taining bacteria.
RESULTS
PGRP-SD Is a Secreted Non-catalytic PGRP Induced by
Infection
PGRP-SD, a secreted protein of 186 amino acid residues, con-
tains a signal peptide and a PGRP domain with no additional1014 Immunity 45, 1013–1023, November 15, 2016regulatory domains (Figure 1A). In the absence of infection,
PGRP-SD is moderately expressed in the fat body, midgut, and
head of adult flies, whereas in larvae it is strongly expressed in
the fat body (Figures S1A and S1B). In a previously published
microarray dataset (De Gregorio et al., 2002), we showed that
PGRP-SD is strongly induced by bacterial challenge in wild-
type flies (Figure S1C). PGRP-SD induction is mediated by the
Imd pathway, but not the Toll pathway (Figure 1B). To analyze
PGRP-SD function, we first tested PGRP-SDD flies (Bischoff
et al., 2004) but realized that none of the available PGRP-SDD3
labeled fly stocks originating from different laboratories carried
the expected PGRP-SDD3 mutation (Figure S1D). This prompted
us to generate two independent PGRP-SD mutant alleles
(PGRP-SDsk1 and PGRP-SDsk2) by using the CRISPR-Cas9
method. Both alleles have a small deletion (Figure 1A), inducing
a frameshift causing a premature stop codon and leading to a
peptide of 50 residues lacking the PGRP domain (Figure S1E).
Given that both alleles behaved similarly, results are shown only
for one of them (PGRP-SDsk1). To eliminate the influence of any
second site mutations and to limit background effect, we back-
crossed the PGRP-SDsk1 mutant seven times to white isogenic
Drosdel flies, and these isogenized flies with their wild-type coun-
terpart were used in all experiments unless stated otherwise.
PGRP-SDsk1 flies exhibited a wild-type lifespan at 29C (Fig-
ure 1C), were viable and fertile, and had no obvious develop-
mental defects, indicating that under normal conditions, the
PGRP-SDsk1 mutation has no detrimental effects on fly physi-
ology. Considering that PGRP-SD is strongly induced by bacte-
rial infection (Figure S1C) and that some PGRPs inmammals and
insects have bactericidal activity, we explored whether PGRP-
SD could function in a similar manner as an effector molecule.
To test whether it participates in bacterial elimination, we moni-
tored the persistence of the Gram-negative bacterium Erwinia
carotovora and the DAP-type Gram-positive bacterium Listeria
monocytogenes in wild-type and PGRP-SDsk1 flies. As shown
by colony-forming unit (CFU) counts (Figures 1D and 1E), the
PGRP-SD mutation did not affect persistence of either bacterial
species. In line with this result, incubation of several bacterial
species with a recombinant PGRP-SD protein did not affect bac-
teria viability in comparison to that of untreated controls (Fig-
ure 1F), indicating that PGRP-SD lacks bactericidal activity.
Moreover, we did not observe any role for PGRP-SD in the mela-
nization response upon septic injury (Figures S1F and S1G).
PGRP-SD Is Not Required for Activation of the Toll
Pathway
Previous studies have suggested a role for PGRP-SD in the acti-
vation of the Toll pathway in response to Lys-type bacteria (Bis-
choff et al., 2004; Wang et al., 2008) or DAP-type Gram-positive
bacteria (Leone et al., 2008). To test the involvement of PGRP-
SD in activation of the Toll pathway, we measured by qRT-PCR
the expression of Drs (the gene that encodes Drosomycin), a
typical readout of the pathway, in PGRP-SDsk1 flies. As shown
in Figures 2A–2C, the level of Drosomycin expression in PGRP-
SDsk1 flies was similar to that in wild-type flies both after infection
with Micrococcus luteus and Enterococcus faecalis and after in-
jection of purified Lys-type peptidoglycan. Consistently, PGRP-
SDsk1 flies did not show an increased susceptibility to these infec-
tions (Figures 2D and 2E). Similarly, knocking down PGRP-SD by
Figure 1. PGRP-SD Is an Inducible Protein Lacking Bactericidal Activity
(A) Schematic representation of the PGRP-SD locus (generated with GSDS 2.0; Hu et al., 2015) and PGRP-SD mutant alleles generated by the CRISPR-Cas9
method. Deleted sequences are represented by a dashed line. The PGRP-SDsk1 allele is caused by an 11 bp deletion (nucleotides 129–139), the PGRP-SDsk2
allele is caused by a 2 nt deletion (130–131) and two nucleotide substitutions. SP, signal peptide; UTR, untranslated region; CDS, coding sequence.
(B) ThePGRP-SDmRNAexpression level in differentmutants after septic injury with amixture of E. coli andM. luteus. The data for this figure (n = 3) were extracted
from De Gregorio et al. (2002).
(C) Lifespan of wild-type (WT) andPGRP-SDmutant flies at 29C (p = 0.2774,WT versus PGRP-SDsk1). The experiment was repeated three timeswith two to three
cohorts of 20 flies within each independent experiment. The results of one representative experiment are shown.
(D and E) Persistence of L. monocytogenes (D) and E. carotovora (E) in PGRP-SDsk1mutants andWT flies (p > 0.8, WT versus PGRP-SDsk1, one-way ANOVA and
Sidak’s test). The horizontal axis indicates the median number of colony-forming units (CFUs) per fly of two experiments, each done in duplicate.
(F) Effect of recombinant PGRP-SD (300 mg/L) on bacterial viability after 4 hr incubation in comparison viability of untreated controls (set to 100%).
Results are shown as means ± SD of three independent experiments. See also Figure S1.RNAi did not lead to reduced Drosomycin expression after
M. luteus infection (Figure S2A).
To test a possible redundancy between PGRP-SD and PGRP-
SA or GNBP1, two known PRRs acting upstream of the
Toll pathway (Gobert et al., 2003; Pili-Floury et al., 2004),
we generated double-mutant PGRP-SAseml;;PGRP-SDsk1 and
GNBP1osi,PGRP-SDsk1 flies. We then infected flies with
M. luteus and Streptococcus pyogenes. Whereas the immune
response to M. luteus is strictly PGRP-SA- and GNBP1-depen-
dent, S. pyogenes has been shown to activate the Toll pathway
in a PGRP-SA- and GNBP1-independent manner (Bischoff et al.,
2004). Nevertheless, it was reported (Bischoff et al., 2004)
that the activation of the Toll pathway by this bacterium was
reduced in a PGRP-SA;;PGRP-SD double mutant, leading
to the initial conclusion that PGRP-SD is involved in the
sensing of certain Gram-positive bacteria upstream of the Toll
pathway. Figures S2B–S2E show, however, that Drosomycin
expression in the double mutant was not significantly different
from its expression in single PGRP-SA or GNBP1 mutants after
challenge with M. luteus and S. pyogenes. In line with this,
double-mutant flies did not exhibit increased susceptibility to
S. aureus and S. pyogenes infection in comparison to PGRP-
SA and GNBP1 single mutants (Figures 2F–2G; Figures S2F
and S2G).We then investigated whether PGRP-SD might be involved in
Toll pathway activation by DAP-type bacteria, as was suggested
by Leone et al. (2008). Again, we did not find evidence for this,
given that Drosomycin expression after challenge with the
DAP-type bacteria Bacillus subtilis and Escherichia coli was
not affected in PGRP-SDsk1 flies (Figure 2H). Thus, in contrast
to previous reports, we did not find that PGRP-SD alone or in
combination with other Toll pathway PRRs was required for
Toll pathway activation in response to Lys- or DAP-type bacteria.
Similarly, results shown in Figures S2H–S2J did not reveal any
role for PGRP-SD in Toll pathway activation by fungi or in resis-
tance to fungi.
Systemic Imd Pathway Activation Is Reduced in
PGRP-SDsk1 Mutant
The facts that PGRP-SD is a DAP-type peptidoglycan-binding
protein (Leone et al., 2008) and is regulated by Relish (Figure 1B)
suggest that it might be involved in the activation of the Imd
pathway. To test this, we monitored by qRT-PCR the expression
of the Imd target gene Diptericin (Dpt) in PGRP-SDsk1 flies in-
fected with the Gram-negative bacteria E. carotovora. We
observed that Dpt expression in PGRP-SDsk1 flies was similar
to that in wild-type flies 1.5 and 3 hr after infection. However,
Dpt expression was significantly lower in the mutants 6 andImmunity 45, 1013–1023, November 15, 2016 1015
Figure 2. Effect of PGRP-SD Mutation on Toll Pathway Activation
(A–C) Induction of Drosomycin (Drs) expression in PGRP-SDsk1 mutants and WT flies in response to systemic challenge withM. luteus (A) and E. faecalis (B) and
injection of E. faecalis peptidoglycan (C).
(D and E) Survival rates of WT and PGRP-SDsk1 mutants systemically infected with E. faecalis (D) and S. aureus (E) (p > 0.4, WT versus PGRP-SDsk1). Flies with a
defective Toll pathway were used as positive controls (p < 0.002, spzrm7 versus PGRP-SDsk1; p < 0.0001, GNBP1 versus PGRP-SDsk1).
(F and G) Survival rates of PGRP-SA (F) and GNBP1 (G) single mutants and of PGRP-SAseml;;PGRP-SDsk1 and GNBP1osi,PGRP-SDsk1 double mutants after
systemic S. aureus infection (p > 0.05, single mutants versus double mutants).
(H) Systemic Toll pathway activation 24 hr after challenge with DAP-type bacteria E. coli and B. subtilis. The experiment was performed in a relishE20 mutant
background lacking a functional Imd pathway to monitor only the contribution of the Toll pathway to Drs expression. The DrsmRNA level inM. luteus-challenged
relish flies was set to 100%, and all other values were expressed as a percentage of this value.
For qRT-PCR results, DrsmRNA levels in challenged WT flies (24 hr) were set to 100%, and all other values were expressed as a percentage of this value. qRT-
PCR results are shown as mean ± SD from ten female flies per genotype from three independent experiments. All survival graphs show one representative
experiment out of three independent repeats with two to three cohorts of 20 male flies per genotype. Two-tailed Student’s t tests were used for data analysis in
(A)–(C) and (H). *p% 0.05; **p% 0.01; ***p% 0.001; ****p% 0.0001; ns (non-significant), p > 0.05. See also Figure S2.24 hr after infection (Figure 3A). This late effect is consistent with
the inducible nature of PGRP-SD in adults, which is hypothe-
sized to accumulate in the hemolymph before it exerts its func-
tion. Similarly, a reduction of Dpt expression was also observed
in larvae systemically infected with E. carotovora (Figure S3A).
Interestingly, we noticed that larvae responded faster and
stronger than adult flies to E. carotovora infection (Figure S3B).
We hypothesized that the higher immune reactivity of larvae
than of adults is due to a high level of PGRP-SD basal expression
at this stage in the absence of infection. Returning to the study
of the adult immune system, we then confirmed the role of
PGRP-SD in Imd pathway activation by two other DAP-type bac-
teria, E. coli and Pseudomonas entomophila. For these two bac-
terial species, the difference in Dpt expression between wild-
type and PGRP-SD mutant flies was even more striking than
with E. carotovora (Figures 3B and 3C). A similar effect was
also observed when the DAP-type Gram-positive bacterium
B. subtilis was used to infect the flies (Figure 3D). Furthermore,
injection of E. coli polymeric peptidoglycan led to a lower Dpt in-
duction in PGRP-SDsk1 flies than in wild-type flies (Figure 3E). A
similar effect of PGRP-SD was also observed for two other anti-
microbial peptide genes regulated by the Imd pathway: Attacin
A1 and Drosocin (Figures S3C–S3H).
A peptidoglycan monomer, GlcNAc-1,6-anhydro-MurNAc-L-
Ala-g-D-Glu-meso-DAP-D-Ala, also called the tracheal cyto-
toxin (TCT), was identified as the minimal peptidoglycan motif
able to elicit an Imd pathway response in Drosophila (Kaneko1016 Immunity 45, 1013–1023, November 15, 2016et al., 2004; Stenbak et al., 2004). Figure 3F shows that injection
of TCT resulted in lower Dpt expression in PGRP-SDsk1 mutants
6 hr after injection. This result indicates that PGRP-SD is required
for proper Imd pathway activation in response to both polymeric
and monomeric DAP-type peptidoglycan. Moreover, injection of
serially diluted, heat-killed E. carotovora or purified E. coli pepti-
doglycan revealed a significantly lower expression of Dpt in
PGRP-SDsk1 mutants at all tested concentrations (Figures 3G;
Figure S3I). Interestingly, the Imd pathway of wild-type flies
strongly responded to E. carotovora even when the optical den-
sity (OD) of the bacterial pellet used to challenge the flies was
0.2, whereas the Imd response of PGRP-SDsk1 flies at this con-
centrationwas not significantly different from that of flies injected
with PBS alone (Figure 3G). Thus, our results indicate that the
role of PGRP-SD in promoting the immune response is particu-
larly important at low elicitor amounts.
We next used an in vivo RNAi approach and rescue experi-
ments to confirm the PGRP-SDsk1mutant phenotypes. Silencing
of PGRP-SD in the fat body (c564-GAL4 and lpp-GAL4 drivers)
or ubiquitously (act5C-GAL4) led to reduced Dpt induction after
E. carotovora challenge. In contrast, RNAi knockdown of PGRP-
SD in hemocytes (hml-GAL4), the midgut (Myo1A-GAL4), or the
nervous system (elav-GAL4) had no effect (Figure 3H). Therefore,
the RNAi experiments confirm the results obtained with the
PGRP-SD mutation and show that its function in the systemic
activation of the Imd pathway requires PGRP-SD expression in
the fat body. Consistent with this, overexpression of PGRP-SD
Figure 3. PGRP-SD Is Required for Systemic Imd Pathway Activation
(A–D) Induction of Diptericin (Dpt) expression in PGRP-SDsk1 mutants and WT flies after systemic infection with E. carotovora OD200 (A), E. coli OD200 (B),
P. entomophila OD1 (C), and B. subtilis OD30 (D).
(E and F) Dpt expression in response to injection of polymeric PGN (E) and monomeric PGN (F) in PGRP-SDsk1 mutants and WT flies.
(G) Dose-dependent response of PGRP-SDsk1 mutants and WT flies to heat-killed E. carotovora. Asterisks indicate significance levels in comparison to those of
PBS-injected flies. One representative experiment out of three is shown.
(H) Effect of tissue-specific PGRP-SD knockdown by RNAi on Dpt expression 6 hr after systemic infection with E. carotovora. Dpt expression in GAL4-driver
stocks crossed with w1118 was set to 100%, and expression in GAL4 stocks crossed with UAS-PGRP-SD-IR was expressed as a percentage of this value.
(I) Tissue-specific rescue of Dpt expression in PGRP-SDsk1 mutants 6 hr after systemic infection with E. carotovora.
(J) Dpt expression in response to systemic E. coli infection in PGRP-SDsk1 mutants and PGRP-SDsk1 mutants transheterozygous with deficiency. Asterisks
indicate significance levels in comparison to those of wild-type flies 6 and 24 hr after infection.
(K–M) Survival rates of PGRP-SDsk1 mutants and WT flies systemically infected with P. entomophila (K, p = 0.0137, WT versus PGRP-SD), B. subtilis (L,
p = 0.0149,WT versusPGRP-SD), andE. carotovora (M, p > 0.05,WT versusPGRP-SD). Flies with a defective Imd pathway (relE20) were used as positive controls.
For qRT-PCR results,DptmRNA levels in challengedWT flies (6 hr) were set to 100%, and all other valueswere expressed as a percentage of this value. qRT-PCR
results are shown as means ± SD from ten female flies per genotype from three independent experiments. Student’s t tests were used for data analysis in (A)–(F);
one-way ANOVAwith Bonferroni post-test was used for data analysis in (H); and two-way ANOVA and Tukey’s post-test were used for data analysis in (G), (I), and
(J). *p% 0.05; **p% 0.01; ***p% 0.001; ****p% 0.0001; ns (non-significant), p > 0.05. See also Figure S3.in the fat body of PGRP-SDsk1 flies (genotype: C564-Gal4/uas-
PGRP-SD; PGRP-SDsk1/PGRP-SDsk1) was sufficient to restore
the strong Dpt expression upon infection with E. carotovora or
E. coli (Figure 3I; Figure S3J). Rescue of the PGRP-SD pheno-
type was also obtained when PGRP-SD was ubiquitously ex-
pressed, but not when it was expressed only in the midgut.
Finally, Dpt activation upon E. coli infection was lower in flies
carrying the PGRP-SDsk1 mutation than in those with a defi-ciency that removes the PGRP-SD locus and some flanking
genes (Figure 3J). Thus, the PGRP-SD phenotype was con-
sistent in two loss-of-function contexts with distinct genetic
backgrounds.
We next investigated whether the loss of PGRP-SD had detri-
mental consequences on the ability of flies to fight off infections.
We observed that PGRP-SDsk1 flies displayed an enhanced sus-
ceptibility to a systemic infection withP. entomophila (Figure 3K):Immunity 45, 1013–1023, November 15, 2016 1017
the survival rate of PGRP-SDsk1 flies was intermediate between
those of Imd-deficient (Relish) and wild-type flies. Moreover,
PGRP-SDsk1 flies showed a higher susceptibility to the Gram-
positive DAP-type B. subtilis than did wild-type flies (Figure 3L).
Nevertheless, PGRP-SDsk1 did not show higher susceptibility to
E. carotovora (OD = 200) infection than did wild-type flies (Fig-
ure 3M). Because E. carotovora is weakly pathogenic, we spec-
ulate that the residual immune response observed in the PGRP-
SD mutant upon E. carotovora infection is sufficient to allow
survival in these conditions.
Collectively, our results demonstrate that PGRP-SD promotes
Imd pathway activation in response to DAP-type bacteria, which
is consistent with its DAP-type peptidoglycan-binding activity
(Leone et al., 2008).
PGRP-SD Functions Upstream of PGRP-LC
Our observation that PGRP-SD, a secreted PGRP with an
affinity for DAP-type peptidoglycan, promotes Imd pathway
activation supports the notion that PGRP-SD functions as a
PRR upstream of the Imd pathway. An attractive hypothesis
would be that PGRP-SD binds to extracellular peptidoglycan
to facilitate its interaction with PGRP-LC. This would be
similar to the function of mammalian secreted CD14, which
binds to lipopolysaccharides (LPSs) in circulation to bring it
in close proximity to the LPS receptor complex composed of
TLR4 and MD2 (Park and Lee, 2013). To test such a model,
we investigated how PGRP-SD interacts with PGRP-LC and
peptidoglycan. Figure 4A shows that overexpression of
PGRP-SD in an otherwise wild-type background did not acti-
vate the Imd pathway in the absence of infection. Overexpres-
sion of PGRP-SD, however, enhanced Imd pathway activation
upon injection of live E. carotovora but only when a low dose
of the bacterium was used (Figures 4A and 4B). In line with
this, PGRP-SD overexpression also enhanced Imd signaling
after injection of polymeric E. coli peptidoglycan and TCT (Fig-
ures S4A and S4B). This indicates that PGRP-SD is not essen-
tial for Imd pathway activation but enhances Imd pathway
function, notably at a low immune elicitor concentration. The
Imd stimulatory effect of PGRP-SD at low bacterial doses
was abolished in PGRP-LC but not in PGRP-LE mutants, con-
firming that PGRP-SD functions upstream of PGRP-LC (Fig-
ure 4C). We observed that the loss of PGRP-SD provoked a
stronger immune deficiency than the loss of PGRP-LE in
response to systemic infection with Gram-negative bacteria
(Figure S3K).
PGRP-SDRe-localizes Peptidoglycan to theCell Surface
To analyze whether PGRP-SD interacts with membrane-bound
PGRP-LC, we performed an immuno-precipitation assay by
incubating PGRP-SD-V5 produced in S2 cells and PGRP-
LCx-GFP protein purified from flies. Whereas no direct interac-
tion between the two proteins was observed, PGRP-LCx co-
purified with PGRP-SD in the presence of E. coli peptidoglycan
(Figure 4D). No interaction was observed in the presence of
monomeric peptidoglycan (TCT). These results suggest that
PGRP-SD might interact with PGRP-LCx but only in the pres-
ence of polymeric peptidoglycan. We then analyzed the impact
of PGRP-SD on Imd pathway activation in cell culture. PGRP-
SD-V5 expressed from a copper-inducible promoter in S2 cells1018 Immunity 45, 1013–1023, November 15, 2016was found in both the cellular fraction (Figure 4E) and the
conditioned media of S2 cells (Figure 4F), confirming that
PGRP-SD is a secreted protein. Additionally, consistent with
the result obtained in vivo (Figure 4A), PGRP-SD by itself did
not induce Dpt expression in S2 cells. Instead, it strongly
enhanced peptidoglycan-mediated induction of Dpt (Figure 4G).
This effect was abolished when PGRP-LCx, but not PGRP-LCa
or PGRP-LCy, was silenced by RNAi (Figure 4H; Figure S5A). A
similar albeit weaker effect was observed when cells were
treated with TCT (Figure 4G). In the case of TCT, both PGRP-
LCx and PGRP-LCa were required for Dpt and Attacin A1 in-
duction (Figure 4H; Figure S5A). Next, to test whether PGRP-
SD promotes peptidoglycan re-localization to the cells, we
imaged biotin-labeled E. coli peptidoglycan incubated with S2
cells with or without PGRP-SD expression. Figure 4I shows a
marked increase in peptidoglycan localization on S2 cells in
the presence of PGRP-SD (Figure 4I; Figure S5B), which
required PGRP-LC (Figures S5C and S5D). Importantly, we
also observed peptidoglycan re-localization to the cell surface
when PGRP-SD was added exogenously to the cells that did
not express PGRP-SD (Figure S5E), indicating that PGRP-SD
functions extracellularly. Consistent with our hypothesis, the
addition of E. coli peptidoglycan also led to an enrichment of
PGRP-SD on S2 cells (Figures 4J; Figure S5F). Thus, PGRP-
SD is a secreted protein that interacts with peptidoglycan
and facilitates their interaction with the cell membrane, where
PGRP-LC is localized.
The Antagonistic Activities of PGRP-SD and PGRP-LB
Shape the Immune Response
Enzymatic PGRPs function extracellularly to scavenge peptido-
glycan, thereby reducing Imd pathway activity (Costechareyre
et al., 2016; Paredes et al., 2011; Zaidman-Re´my et al., 2006).
Among them, PGRP-LB has enzymatic activity against DAP-
type peptidoglycan and is regulated at the transcriptional level
by the Imd pathway to provide a negative feedback loop on the
pathway (Zaidman-Re´my et al., 2006). Although PGRP-SD and
PGRP-LB have opposite functions, they share many similarities
because they are both secreted, are upregulated upon infection
by the Imd pathway, and display binding specificity to DAP-type
peptidoglycan. We generated PGRP-SDsk1,LBD double-mutant
flies toanalyze the interactionbetween these twoextracellular reg-
ulators. As expected,PGRP-LBmutants showedamuch stronger
Dpt expression than wild-type flies after E. carotovora systemic
infection (Figure 5A). Interestingly, wild-type levels of Dpt expres-
sion were observed in the PGRP-SDsk1,LBD double-mutant flies
(Figure5A). This indicates that theabsenceofPGRP-SDcancoun-
teract the excessive activation of the Imd pathway in PGRP-LBD
flies. The same result was observed with E. coli (Figures 5B and
5C). PGRP-LB-deficient flies showed a lower survival rate in
response to oral bacterial infection and lower longevity as a result
of chronic activation of the Imd pathway (Paredes et al., 2011).
Consistent with this, the PGRP-SDsk1 mutation suppressed the
PGRP-LBDprecocious lethality toE. carotovoraoral infection (Fig-
ure 5D). Moreover, PGRP-SDsk1,LBD double-mutant flies ex-
hibited a wild-type lifespan at 29C, whereas PGRP-LBD flies
were short lived (Figure 5E). Collectively, our results show that
two secreted PGRPs with antagonistic activities function up-
stream of PGRP-LC to modulate the level of Imd signaling.
Figure 4. PGRP-SD Acts Upstream of PGRP-LC to Facilitate Peptidoglycan Sensing and Imd Pathway Activation
(A) Effect of PGRP-SD overexpression in the fat body on Dpt induction after systemic infection with E. carotovora.
(B) Dpt induction after systemic infection with E. carotovora in a PGRP-SD-overexpressing line and a control line over time.
(C) Effect of PGRP-SD overexpression in the fat bodies of Imd pathwaymutants onDpt induction after systemic infection with E. carotovora. Results are shown as
mean ± SD from ten female flies per genotype from at least three independent experiments.
(D) PGRP-SD co-immunoprecipitated with PGRP-LCx in the presence of PGN. Affinity-purified PGRP-LCx-GFP pulled down PGRP-SD-V5 from S2 cellular
extracts in the presence of PGN. One representative blot is shown out of two repeats.
(E and F) Detection of PGRP-SD-V5 (25 kDa) by anti-V5 immunoblot of lysates (E) and culture media (F) of S2 cells expressing V5-tagged PGRP-SD. A non-
specific band at 55 kDa was used as a loading control (E). A representative blot out of two independent assays is shown.
(G) Dpt induction by peptidoglycan and TCT in S2 cells overexpressing PGRP-SD. S2 cells transfected with copper-inducible PGRP-SD-encoding plasmid were
induced with copper sulfate (0.5 mM) for 24 hr and treated with E. coli peptidoglycan (10 mg/mL) or TCT (1 mM) for the indicated time points. Dpt expression in
unchallenged cells at 24 hr was set to 1, and all other values were calculated in relation to this value. Asterisks indicate significance levels in comparison to those
of unchallenged cells. Results are shown as mean ± SD of three independent experiments.
(H) Effect of isoform-specific PGRP-LC knockdown by RNAi on PGRP-SD-mediated activation of Imd pathway by E. coli peptidoglycan and TCT. Results are
shown as mean ± SD of three independent experiments.
(I) Effect of PGRP-SD overexpression on peptidoglycan localization in S2 cells. PGRP-SD-expressing (S2+PGN+PGRP-SD) and non-expressing (S2+PGN) cells
were treated with peptidoglycan and stained with DAPI (blue) and anti-biotin (to detect biotinylated peptidoglycan, stained in red). Shown is a representative
experiment out of two.
(J) Effect of peptidoglycan on PGRP-SD localization in S2 cells. Untreated cells (S2), cells that expressed PGRP-SD-V5 (S2+PGRP-SD), and cells that expressed
PGRP-SD-V5 in the presence of E. coli peptidoglycan (S2+PGN+PGRP-SD) were stained with anti-V5 to detect PGRP-SD (shown in green) and DAPI (blue).
Shown is a representative experiment out of two.
One-way ANOVAwith Tukey’s post-test was used for data analysis in (C), two-way ANOVA and Tukey’s post-test were used for data analysis in (G); and Student’s
t tests were used for data analysis in (A) and (B). *p% 0.05; **p% 0.01; ***p% 0.001; ****p% 0.0001; ns (non-significant), p > 0.05. See also Figure S4 and S5.
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Figure 5. The PGRP-SD Mutation Counterbalances the Excessive Immune Activation in PGRP-LB Mutant Flies
(A) Effect of PGRP-SD mutation on Dpt expression level in PGRP-LB mutants after E. carotovora systemic infection.
(B and C) Effect of PGRP-SD mutation on Attacin A1 (B) and Drosocin (C) expression in PGRP-LB mutants after E. coli systemic infection.
(D) Survival rates of PGRP-LB flies alone or in combination with PGRP-SDsk1 after E. carotovora oral infection (p > 0.4, WT versus LB,SD; p < 0.002, LB versus
LB,SD).
(E) Lifespan of PGRP-LB,SD double mutants and PGRP-LB and PGRP-SDsk1 single mutants (p > 0.2, WT versus LB,SD; p < 0.0001, LB versus LB,SD).
For qRT-PCR results,DptmRNA levels in challengedWT flies (6 hr) were set to 100%, and all other valueswere expressed as a percentage of this value. qRT-PCR
results are shown as mean ± SD from ten female flies per genotype from three independent experiments. Two-way ANOVA and Tukey’s post-test were for data
analysis in (A)–(C). *p% 0.05; **p% 0.01; ***p% 0.001; ****p% 0.0001; ns (non-significant), p > 0.05.DISCUSSION
For a long time, PGRP-SD was considered to be a PRR for
Gram-positive bacteria and to function redundantly with
PGRP-SA and GNBP1 upstream of the Toll pathway (Bischoff
et al., 2004). Little attention had been devoted to conflicting
structural and in vitro binding data showing that PGRP-SD binds
DAP-type and not Lys-type peptidoglycans (Leone et al., 2008)
or to gene-expression profiling showing that PGRP-SD is a
bona fide Imd pathway target (De Gregorio et al., 2002). Using
newly generated PGRP-SD mutations, we have addressed this
inconsistency and conclusively demonstrated that PGRP-SD is
a PRR for DAP-type bacteria and has an essential function in
Imd pathway activation. This conclusion is supported by the
fact thatPGRP-SDmutants exhibit reduced Imd pathway activa-
tion after challenge with a number of DAP-type bacteria, as well
as both polymeric and monomeric peptidoglycans. We have
shown that PGRP-SD co-immunoprecipitates with PGRP-LCx
in the presence of peptidoglycan and enhances peptido-
glycan-mediated activation of the Imd pathway in a PGRP-LC-
dependent manner. Additional biochemical and cell-culture
experiments revealed that PGRP-SD promotes peptidoglycan
concentration at the proximity of the cell membrane in a
PGRP-LC-dependent manner. This suggests a model in which
PGRP-SD binds to peptidoglycan in the extracellular compart-
ment and facilitates peptidoglycan concentration at the cell sur-
face, where PGRP-SD-peptidoglycan complexes interact with
the cell-surface receptor PGRP-LC to activate the Imd pathway.
Contrary to previous studies using the ‘‘PGRP-SDD3’’ fly stock1020 Immunity 45, 1013–1023, November 15, 2016(Bischoff et al., 2004; Leone et al., 2008; Wang et al., 2008),
our data do not reveal a role for PGRP-SD, alone or in combina-
tion with PGRP-SA and GNBP1, in activation of the Toll pathway
by Lys- or DAP-type bacteria. Given that none of thePGRP-SDD3
labeled stocks we obtained appeared to carry the expected
PGRP-SD mutation (Figure S1D), we hypothesize that the orig-
inal PGRP-SDD3 fly stock was either initially mischaracterized
or rapidly contaminated by a wild-type stock. Our results indi-
cate that the role previously allocated to PGRP-SD as the
PGRP-SA-GNBP1 co-receptor either is executed by another
protein or has to be explained by another process.
Themode of action of PGRP-SD is strongly evocative of that of
soluble CD14, which plays an important role upstreamof TLR4 to
capture extracellular LPS and bring it to the proximity of a
signaling receptor complex composed of MD2 and TLR4 (Park
and Lee, 2013; Pugin et al., 1993). CD14 has been shown to un-
derlie the high sensitivity of some mammalian species to LPS
(Lee et al., 1992). Similarly, the presence of PGRP-SD contrib-
utes to the high sensitivity of Drosophila to DAP-type peptido-
glycan, but in contrast to PGRP-LC, it is not mandatory for Imd
pathway activation when a high dose of immune elicitor is pre-
sent. Such a high sensitivity of the Imd pathway can be critical
in sensing Gram-negative bacteria, which release only low
amounts of peptidoglycan, because it is hidden under the LPS
layer. An interesting observation was that PGRP-SD also sensi-
tized the Imd pathway to monomeric peptidoglycan, although
the stimulatory effect was less marked than with polymeric
peptidoglycan. Although we did observe a stimulatory effect of
PGRP-SD on TCT sensing in both flies and S2 cells, we did not
detect any biochemical interaction with PGRP-LCx. It is possible
that the assay was not sensitive enough to detect such an inter-
action or that PGRP-SD interacts with another PGRP-LC iso-
form. An attractive hypothesis is that PGRP-SD oligomerizes
upon TCT binding, as previously shown for the intracellular
sensor PGRP-LE (Lim et al., 2006), and that PGRP-SD-TCT com-
plexes then interact with PGRP-LCx/a. Future research should
address the mechanism by which the peptidoglycan-PGRP-SD
complex leads to dimerization of PGRP-LC and subsequent
activation of Imd signaling and clarify how PGRP-SD interacts
with TCT.
PGRP-SD is not the first PRR reported to act extracellularly
upstream of PGRP-LC. A previous study has revealed the ex-
istence of an extracellular form of PGRP-LE, named PGRP-
LEpg, which can potentiate PGRP-LC activation by TCT (Ka-
neko et al., 2006). The absence of a signal peptide sequence
in PGRP-LE and the observation that a PGRP-LE-GFP re-
porter localizes strictly intracellularly (Bosco-Drayon et al.,
2012) question the existence of this extracellular PGRP-LE
isoform and its precise role. Compared to that of PGRP-LE,
inactivation of PGRP-SD induced a stronger immune defect,
indicating that PGRP-SD has an important role in the activa-
tion of PGRP-LC during Gram-negative bacterial infection. It
cannot be excluded that the main role of PGRP-SD is to
enhance PGRP-LC activation by DAP-type polymeric peptido-
glycan, whereas the role of extracellular PGRP-LEpg is
restricted to TCT sensing. This would explain why PGRP-SD
has a modest effect on TCT sensing. Future studies should
determine whether PGRP-LE indeed functions extracellularly
and analyze its interaction with PGRP-SD. Another interesting
line of research would be to investigate the role of PGRP-SD in
the gut immune response, given that it is also expressed in the
intestinal epithelium.
Finally, our study underlines how tightly the Imd pathway is
regulated by both negative and positive regulators extracellu-
larly in the hemolymph. Although our data suggest that the
main role of PGRP-SD is to present peptidoglycan to PGRP-
LC at the cell membrane, it is possible that PGRP-SD also pro-
tects peptidoglycan from being scavenged by enzymatic
PGRPs. The observation that PGRP-SDsk1,LBD flies have an
apparent wild-type immune response is at first puzzling and
raises the question of the necessity of two such antagonistic
activities. The existence of these regulators might provide
robustness to the immune system to generate a range of
immune responses. This could also provide regulatory flexibility
by adjusting the immune reactivity in a stage- and tissue-spe-
cific manner through the modulation of PGRP-LB and PGRP-
SD expression rather than by changing cellular core compo-
nents of the pathway. Consistent with this hypothesis, the
presence of PGRP-SD in the hemolymph of unchallenged
larvae as a result of high basal transcriptional expression might
explain the faster immune reactivity of larvae than of adults,
where induced PGRP-SD needs to be accumulated to enhance
Imd-immune activation.
Over the last two decades, it has been recognized that micro-
bial recognition by the innate immune system is much more
complex than the simple molecular contact between a host
PRR and a microbial molecule. Pattern recognition is increas-
ingly viewed as a multistep process with additional host factorsinvolved upstream of recognition, including the degradation of
bacterial cell-wall compounds and/or the transport of microbial
ligands to the signaling receptors. By adding PGRP-SD to the
list of PGRPs involved in the sensing of DAP-type peptidoglycan
upstreamof the Imd pathway, our study uncovers the complexity
of pattern recognition in Drosophila while revealing general prin-
ciples of innate immune sensing.
EXPERIMENTAL PROCEDURES
Standard methods of molecular biology, microbiology, and biochemistry can
be found in the Supplemental Experimental Procedures.
Fly Stocks and Mutant Generation
DrosDel w1118 iso isogenic flies described previously (Ryder et al., 2004) and
y,w flies were used as wild-type controls. The spzrm7,GNBP1osi,PGRP-SAseml,
relE20, PGRP-LCE12, PGRP-LE112, PGRP-LBD, and UAS-PGRP-LCx-GFP flies
have been described previously (Gobert et al., 2003; Gottar et al., 2002; Neyen
et al., 2012; Paredes et al., 2011; Schmidt et al., 2008; Takehana et al., 2004).
UAS-PGRP-SD-IR (56952) and Df(3L)BSC388 (24412) were obtained from the
Bloomington Stock Center. For the generation of UAS-PGRP-SD transgenic
flies, a full-length cDNA of PGRP-SD was cloned into the pENTR-D-TOPO
Gateway vector (Invitrogen) and finally swapped into the pTW transgenesis
vector. The transgenic flies were obtained by P-element transgenesis.
PGRP-SDsk1 and PGRP-SDsk2 flies were generated by the CRISR-CAS9
method, as described previously (Kondo and Ueda, 2013). PGRP-SDsk1 and
PGRP-LBD mutations were introduced into the w1118 DrosDel iso isogenic
background by chromosomes replacement and backcrossing as described
in Ryder et al. (2004). Isogenic spzrm7, PGRP-LCE12, relE20, and
DrosDel w1118 iso lines were kindly provided by Luis Teixeira (Portugal).
Drosophila stocks were maintained at 25C on standard cornmeal-agar fly
medium.
qRT-PCR
For quantification of mRNA, whole flies were collected at the indicated time
points. Total fly RNA was isolated from 10–15 adult flies by TRIzol reagent
and dissolved in RNase-free water. A total of 500 ng RNA was then reverse
transcribed in 10 mL reaction volume with PrimeScript RT (TAKARA) and
random hexamer primers. qPCR was performed on a LightCycler 480 (Roche)
in 96-well plates with Applied Biosystems SYBR Green PCR Master Mix.
Primer sequences were published elsewhere (Neyen et al., 2014).
PGRP-SD Expression in S2 Cells
S2 cells were cultured in Schneider’s medium (Invitrogen) supplemented
with 10% heat-inactivated FBS and penicillin (10 U/mL) and streptomycin
(100 mg/mL) at 25C. For immune stimulation, E. coli peptidoglycan at a final
concentration of 10 mg/mL and TCT at a final concentration of 1 mMwere used.
RNA extraction, reverse transcription, and qPCRwere performed as described
for fly tissues.
For protein expression, PGRP-SD cDNA was cloned into a pMT-V5-His
vector (Invitrogen). Obtained pMT-PGRP-SD-V5-His plasmid was transfected
into S2 cells with Lipofectamine 2000 Reagent (Invitrogen) according to the
manufacturer’s instructions. PGRP-SD expression was induced by the
addition of 0.5 mM CuSO4. Protein expression was verified by western blot
with the use of mouse monoclonal anti-V5 (Dianova) antibodies (1:1,000)
and anti-mouse HRP-conjugated (Jackson Immunoreseach) secondary anti-
bodies (1:10,000). Western blots were visualized with ECL western blotting
detection reagents (GE Healthcare) and exposure to an X-ray film (Kodak).
The time-dependent effect of PGRP-SD expression on peptidoglycan- and
TCT-induced Dpt levels in S2 cells was evaluated as follows. S2 cells
were transiently transfected with pMT-PGRP-SD-V5-His plasmid, and 24 hr
post-transfection PGRP-SD expression was induced by CuSO4. E. coli pepti-
doglycan (10 mg/mL final concentration) or TCT (1 mM) was added 24 hr after
induction. Cells were harvested every 24 hr during a 4 day period for the
gene-expression analysis. PGRP-LC knockdown by RNAi was achieved by
transfection of S2 cells with double-stranded RNA (dsRNA). dsRNA was syn-
thesized with the MEGAscript T7 Kit (Invitrogen).Immunity 45, 1013–1023, November 15, 2016 1021
Statistical Analysis
All analyses were performed with GraphPad Prism software version 6.05.
Survival curves were compared by log-rank tests; p values were Bonferroni
corrected where multiple comparisons were necessary. All other data were
analyzed by Student’s t test or one-way or two-way ANOVA, as well as appro-
priate Dunnett, Tukey, Bonferroni, or Sidak post hoc tests.
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Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.immuni.2016.10.029.
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